Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-AnalysisDan Rosmarin, Ian D. Tomlinson, Enric Domingo et al.|Journal of Clinical Oncology|2014Cited by 261
Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.Shibani Nicum, Claire Brooks, Rose Wharton et al.|Journal of Clinical Oncology|2013Cited by 1